Sharemaestro company-news research for Medicenna Therapeutics Corp. (MDNA), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.

TOR Canada Provisional evidence

Company news sentiment

Latest MDNA news and sentiment

Medicenna Therapeutics Corp.

Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.

Full chart Weekly report Factor research RSS feed
30-day score50Neutral is 50
Early balanced news score 16/100 evidence confidence 100% direct company focus 22 current stories across 5 publishers
Latest weekly closeCAD 0.47week of 4 Sep 2026
Main news subjectMarket update87/100 share of current news
News data statusPartial6 duplicate stories removed

Current company news

Early balanced news score

22 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.

Observed headline tone56/100 Published 30-day score50/100

Older, less relevant and less reliable stories count for less. Confidence is shown separately.

Latest source headline Medicenna Therapeutics Stock Price Forecast. Should You Buy MDNA.TO? StockInvest.us · 04 Sep 2026 23:59

What supports the score

Direct evidence

22 current stories are mapped specifically to MDNA.

Source breadth

The score uses 5 publishers rather than depending on one outlet.

What limits the score

Too little evidence

The stories agree, but freshness-weighted evidence is only 0.022.

Confidence

Confidence is 16/100, below the threshold for a firm score.

50/100
News scoreEarly balanced news score
16/100
Confidencethin evidence
100%/100
Company news22 company stories
81/100
Story agreement19/100 difference

News history

Daily score and story count over 30 days

Daily weighted evidence
14 Aug: 5 stories17 Aug: 3 stories18 Aug: 2 stories20 Aug: 1 stories24 Aug: 1 stories26 Aug: 2 stories31 Aug: 4 stories02 Sep: 1 stories03 Sep: 1 stories04 Sep: 1 stories 14 Aug: tone 38, 5 stories17 Aug: tone 43, 3 stories18 Aug: tone 75, 2 stories20 Aug: tone 38, 1 stories24 Aug: tone 50, 1 stories26 Aug: tone 56, 2 stories31 Aug: tone 50, 4 stories02 Sep: tone 50, 1 stories03 Sep: tone 50, 1 stories04 Sep: tone 50, 1 stories 95505
11 Aug26 Aug09 Sep
News scoreStory count50 baseline

Confidence

How reliable the score is

Separate from direction

Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.

Amount of evidence0
0.022 after freshness weighting
Source breadth100
5 independent publishers
Company relevance100
share tied directly to this company
Freshness31
recency-weighted evidence
Agreement81
how closely stories agree
Publisher mix62
less reliance on one publisher

Price and news history

Weekly price and news-score history

Early company-news score

Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.

26 completed price weeks11 comparable news-score weeks
One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
13 Mar 2026: close 0.77, indexed 100.020 Mar 2026: close 0.7, indexed 90.927 Mar 2026: close 0.63, indexed 81.803 Apr 2026: close 0.62, indexed 80.510 Apr 2026: close 0.65, indexed 84.417 Apr 2026: close 0.61, indexed 79.224 Apr 2026: close 0.65, indexed 84.401 May 2026: close 0.61, indexed 79.208 May 2026: close 0.63, indexed 81.815 May 2026: close 0.54, indexed 70.122 May 2026: close 0.455, indexed 59.129 May 2026: close 0.425, indexed 55.205 Jun 2026: close 0.45, indexed 58.412 Jun 2026: close 0.42, indexed 54.519 Jun 2026: close 0.43, indexed 55.826 Jun 2026: close 0.405, indexed 52.603 Jul 2026: close 0.395, indexed 51.310 Jul 2026: close 0.37, indexed 48.117 Jul 2026: close 0.35, indexed 45.524 Jul 2026: close 0.35, indexed 45.531 Jul 2026: close 0.36, indexed 46.807 Aug 2026: close 0.375, indexed 48.714 Aug 2026: close 0.46, indexed 59.721 Aug 2026: close 0.41, indexed 53.228 Aug 2026: close 0.475, indexed 61.704 Sep 2026: close 0.47, indexed 61.0 26 Jun 2026: news score 50, close 0.405, 2 stories5003 Jul 2026: news score 50, close 0.395, 4 stories10 Jul 2026: news score 50, close 0.37, 6 stories5017 Jul 2026: news score 50, close 0.35, 7 stories24 Jul 2026: news score 50, close 0.35, 7 stories5031 Jul 2026: news score 49, close 0.36, 11 stories07 Aug 2026: news score 50, close 0.375, 9 stories5014 Aug 2026: news score 47, close 0.46, 14 stories21 Aug 2026: news score 51, close 0.41, 19 stories5128 Aug 2026: news score 51, close 0.475, 18 stories04 Sep 2026: news score 50, close 0.47, 22 stories50 Price index 106.5 72.7 38.9 News score 100 50 0
13 Mar09 Jun04 Sep
Weekly close, indexedSentiment score
26-week price-39.0%latest close 0.47
News score change+0first to latest comparable week
One-week response-1.1%Price digesting
Fair-value position-59.4%Below fair value
WeekNews scoreCloseWeekly move
04 Sep 202650CAD 0.47-1.1%
28 Aug 202651CAD 0.475+15.9%
21 Aug 202651CAD 0.41-10.9%
14 Aug 202647CAD 0.46+22.7%
07 Aug 202650CAD 0.375+4.2%
31 Jul 202649CAD 0.36+2.9%
24 Jul 202650CAD 0.35+0.0%
17 Jul 202650CAD 0.35-5.4%
Provisional evidence

News subjects

What is shaping the score

Market update
Market update5017 stories · 77%
Earnings554 stories · 18%
Guidance501 stories · 5%

Source mix

Where the evidence comes from

62/100 independence
Wealth Awesome6710 stories · 45%
kalkine.ca504 stories · 18%
GlobeNewswire502 stories · 9%
scanx.trade321 stories · 5%
TipRanks431 stories · 5%
MT Newswires431 stories · 5%
StockInvest.us501 stories · 5%

Recurring subjects

Subjects appearing most often

Current evidence

Topic structure will appear when classified tags are present in the current feed.

Earlier readings

How the score has changed

24 comparable readings · 75 days
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
Comparable move+050 to 50 · Broadly stable
Observed range47–5250 is the neutral baseline
Evidence depth22stories at latest stored reading · +21
Confidence16/100Provisional · -12
21 Jun50 neutral04 Sep 23:59
ConstructiveBalanced or withheldCautious

Changes in the stored score

Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.

ObservedScoreMoveConfidenceStoriesStatus
04 Sep 23:5950+016/100 (0)22 (+1)Provisional
03 Sep 23:5950+016/100 (-1)21 (+1)Provisional
02 Sep 23:5950+017/100 (-1)20 (+1)Provisional
31 Aug 23:5950-118/100 (-7)19 (+1)Provisional
26 Aug 23:5951+025/100 (+2)18 (0)Provisional
24 Aug 23:5951+023/100 (-8)18 (-1)Provisional
20 Aug 23:5951-131/100 (-2)19 (+1)Provisional
18 Aug 23:5952+333/100 (+2)18 (+2)Provisional

Source headlines

The news behind the score

Showing 1-22 of 22

Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.

#1—Not directional
StockInvest.usDirect company coverageScored from headline

Medicenna Therapeutics Stock Price Forecast. Should You Buy MDNA.TO?

Published
04 Sep 2026 23:59
News subject
Guidance
Why this score
The headline reports news without a clear direction
Company focus
Main company · 100%
How it is used
Shown as company news · not used in the score
Story strength
Not directional
30-day weight
None · 4.4d old
Duplicates
1 consolidated
#2—Not directional
GlobeNewswireDirect company coverageScored from headline

Medicenna to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Published
03 Sep 2026 11:00
News subject
Market update
Why this score
The headline reports news without a clear direction
Company focus
Main company · 100%
How it is used
Shown as company news · not used in the score
Story strength
Not directional
30-day weight
None · 6.0d old
Duplicates
1 consolidated
#3—Not directional
kalkine.caDirect company coverageScored from headline

Medicenna Therapeutics Corp. (TSX: MDNA) Stock Analysis: Could 2026 Be a Defining Year?

Published
02 Sep 2026 08:07
News subject
Market update
Why this score
The headline reports news without a clear direction
Company focus
Main company · 100%
How it is used
Shown as company news · not used in the score
Story strength
Not directional
30-day weight
None · 7.1d old
Duplicates
1 consolidated
#5—Not directional
Wealth AwesomeDirect company coverageScored from headline

Why Medicenna Therapeutics Corp stock went up yesterday

Published
31 Aug 2026 13:02
News subject
Market update
Why this score
The headline reports news without a clear direction
Company focus
Main company · 100%
How it is used
Shown as company news · not used in the score
Story strength
Not directional
30-day weight
None · 8.9d old
Duplicates
1 consolidated
#7—Not directional
Wealth AwesomeDirect company coverageScored from headline

What's Going On With Medicenna Therapeutics Corp Stock Sunday?

Published
31 Aug 2026 00:31
News subject
Market update
Why this score
The headline reports news without a clear direction
Company focus
Main company · 100%
How it is used
Shown as company news · not used in the score
Story strength
Not directional
30-day weight
None · 9.4d old
Duplicates
1 consolidated
#8—Not directional
Kalkine MediaDirect company coverageScored from headline

Could Medicenna Therapeutics (TSX:MDNA) Unlock Its Next Biotech Catalyst?

Published
26 Aug 2026 19:27
News subject
Market update
Why this score
The headline reports news without a clear direction
Company focus
Main company · 100%
How it is used
Shown as company news · not used in the score
Story strength
Not directional
30-day weight
None · 13.6d old
Duplicates
1 consolidated
#960Tone
Wealth AwesomeDirect company coverageScored from headline

Why Medicenna Therapeutics Corp stock surged yesterday

Published
26 Aug 2026 12:22
News subject
Market update
Why this score
Positive market reaction
Company focus
Main company · 100%
How it is used
Direct company coverage
Story strength
Low · 33/100
30-day weight
3.5% of the score · 13.9d old
Duplicates
1 consolidated
#10—Not directional
Wealth AwesomeDirect company coverageScored from headline

What's Going On With Medicenna Therapeutics Corp Stock Sunday?

Published
24 Aug 2026 02:30
News subject
Market update
Why this score
The headline reports news without a clear direction
Company focus
Main company · 100%
How it is used
Shown as company news · not used in the score
Story strength
Not directional
30-day weight
None · 16.3d old
Duplicates
1 consolidated
#1138Tone
Wealth AwesomeDirect company coverageScored from headline

Why Medicenna Therapeutics Corp stock fell yesterday

Published
20 Aug 2026 13:06
News subject
Market update
Why this score
Negative market reaction
Company focus
Main company · 100%
How it is used
Direct company coverage
Story strength
Low · 34/100
30-day weight
0.5% of the score · 19.9d old
Duplicates
1 consolidated
#12—Not directional
Wealth AwesomeDirect company coverageScored from headline

Why Medicenna Therapeutics Corp stock is tanking today

Published
18 Aug 2026 18:31
News subject
Market update
Why this score
The headline reports news without a clear direction
Company focus
Main company · 100%
How it is used
Shown as company news · not used in the score
Story strength
Not directional
30-day weight
None · 21.7d old
Duplicates
1 consolidated
#1375Tone
Wealth AwesomeDirect company coverageScored from headline

Medicenna Therapeutics Corp MDNA Earnings Beat Estimates by 0.0%

Published
18 Aug 2026 11:03
News subject
Earnings
Why this score
Beat expectations
Company focus
Main company · 100%
How it is used
Direct company coverage
Story strength
Medium · 55/100
30-day weight
46.6% of the score · 22.0d old
Duplicates
1 consolidated
#1565Tone
kalkine.caDirect company coverageScored from headline

TSX:MDNA Jumps 15%: What Is Driving Medicenna Therapeutics Stock Higher?

Published
17 Aug 2026 07:00
News subject
Market update
Why this score
Large positive market reaction
Company focus
Main company · 100%
How it is used
Direct company coverage
Story strength
Medium · 37/100
30-day weight
0.2% of the score · 23.1d old
Duplicates
1 consolidated
#16—Not directional
Wealth AwesomeDirect company coverageScored from headline

What's Going On With Medicenna Therapeutics Corp Stock Sunday?

Published
17 Aug 2026 00:01
News subject
Market update
Why this score
The headline reports news without a clear direction
Company focus
Main company · 100%
How it is used
Shown as company news · not used in the score
Story strength
Not directional
30-day weight
None · 23.4d old
Duplicates
1 consolidated
#1743Tone
MT NewswiresDirect company coverageScored from headline

Medicenna Q2 Net Loss Flat at C$0.06 Per Share

Published
14 Aug 2026 17:21
News subject
Market update
Why this score
Negative financial language
Company focus
Main company · 100%
How it is used
Direct company coverage
Story strength
Low · 28/100
30-day weight
<0.1% of the score · 25.7d old
Duplicates
1 consolidated
#18—Not directional
marketscreener.comDirect company coverageScored from headline

Medicenna Therapeutics Corp. Reports Earnings Results for the First Quarter Ended June 30, 2026

Published
14 Aug 2026 16:22
News subject
Market update
Why this score
The headline reports news without a clear direction
Company focus
Main company · 100%
How it is used
Shown as company news · not used in the score
Story strength
Not directional
30-day weight
None · 25.8d old
Duplicates
1 consolidated
#19—Not directional
Wealth AwesomeDirect company coverageScored from headline

Why Medicenna Therapeutics Corp stock is skyrocketing today

Published
14 Aug 2026 14:21
News subject
Market update
Why this score
The headline reports news without a clear direction
Company focus
Main company · 100%
How it is used
Shown as company news · not used in the score
Story strength
Not directional
30-day weight
None · 25.8d old
Duplicates
1 consolidated
#20—Not directional
GlobeNewswireDirect company coverageScored from headline

Medicenna Therapeutics Reports First Quarter Fiscal 2027 Financial Results and Announces Oral Presentations at Upcoming Conferences

Published
14 Aug 2026 11:00
News subject
Earnings
Why this score
The headline reports news without a clear direction
Company focus
Main company · 100%
How it is used
Shown as company news · not used in the score
Story strength
Not directional
30-day weight
None · 26.0d old
Duplicates
1 consolidated
#2132Tone
scanx.tradeDirect company coverageScored from headline

Medicenna Q1 EPS meets consensus at $(0.06); loss widens to $5.1m

Published
14 Aug 2026 07:00
News subject
Earnings
Why this score
Loss widened
Company focus
Main company · 100%
How it is used
Direct company coverage
Story strength
Medium · 47/100
30-day weight
22% of the score · 26.1d old
Duplicates
1 consolidated
#2238Tone
Wealth AwesomeDirect company coverageScored from headline

Why Medicenna Therapeutics Corp stock fell yesterday

Published
10 Aug 2026 12:22
News subject
Market update
Why this score
Negative market reaction
Company focus
Main company · 100%
How it is used
Direct company coverage
Story strength
Low · 34/100
30-day weight
<0.1% of the score · 29.9d old
Duplicates
1 consolidated

Earlier company news

MDNA news archive

13 older headlines

Stored newest first for historical research. It starts after the newest three pages above and then continues through older news. Each archive page is loaded only when it is opened.

Older news is kept in the archive

There are 13 older MDNA headlines. Open one page at a time when you need them.

Open older archive

Provider matches checked

Provider mentions not used in the score

1 not scored

A news provider linked these stories to MDNA, but the headline and available text are not mainly about Medicenna Therapeutics Corp.. They are kept here for transparency and do not affect the score, confidence, history or wider market totals.

Provider mentions are kept separate

Open the list to see which provider matches were checked and left out of MDNA sentiment.

Open provider mentions

How the page works

How to read the score

The score shows direction

It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.

Confidence is separate

Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.

Price is confirmation

Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.

What the page does

It measures news already published. It is not a forecast, recommendation or price target.

Evidence context